SCHEMBL7952076

SCHEMBL7952076

O=C(OCC(Cl)(Cl)Cl)N1C2CCC1CC(Sc1ccc(F)cc1)C2

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 9/20 0.41
GRIN1 Q05586 2/20 0.39
GRIN2B Q13224 2/20 0.39
GPR119 Q8TDV5 1/20 0.35
OPRM1 P35372 1/20 0.34
OPRK1 P41145 1/20 0.34
KCNH2 Q12809 1/20 0.34
GRM5 P41594 1/20 0.33
CHRM2 P08172 2/20 0.33
CHRM3 P20309 2/20 0.33
CHRM4 P08173 2/20 0.33
LTA4H P09960 1/20 0.32
CHRM5 P08912 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7940656 0.89 CTSS (0.36) CHRM1OPRM1OPRK1KCNH2CHRM2
SCHEMBL7335086 0.88 OPRM1 (0.44) CHRM1GRIN1GRIN2BOPRM1OPRK1
SCHEMBL4487010 0.86 GRIN1 (0.43) CHRM1GRIN1GRIN2BCHRM2CHRM3
SCHEMBL2190030 0.72 CHRM1 (0.54) CHRM1GPR119CHRM2CHRM3CHRM4
SCHEMBL2190026 0.72 CHRM1 (0.54) CHRM1GPR119CHRM2CHRM3CHRM4
SCHEMBL8814399 0.72 GRIN1 (0.40) CHRM1GRIN1GRIN2BCHRM2CHRM3
SCHEMBL857819 0.71 CHRM1 (0.38) CHRM1GPR119CHRM2CHRM3CHRM4
SCHEMBL7560109 0.71 SLC6A3 (0.41) CHRM1CHRM2CHRM3CHRM4
SCHEMBL6991525 0.70 SIGMAR1 (0.36) CHRM1
SCHEMBL12507091 0.70 CHRM1 (0.37) CHRM1GPR119CHRM2CHRM3CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6258827-B1 HYDROXYAROMATIC HETEROCYCLIC ALKANOLS AND LEVODOPA PFIZER INC. 2001-07-10 US disclosed
US-6046213-A Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives PFIZER INC. (US) 2000-04-04 US disclosed
EP-0828513-A2 COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS PFIZER INC. (US) 1998-03-18 EP disclosed
WO-1996037226-A2 COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS PFIZER INC. (US) 1996-11-28 WO disclosed